Evidence map›Paper›PMID 35567237›Full record

ReviewPlants (Basel, Switzerland)2022

Understanding

David Charles Simiyu, Jin Hoon Jang, Ok Ran Lee

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Genetic Advances inPlants (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Role of the Endocannabinoid System in Fibromyalgia.Current issues in molecular biology · 2025
    Review
  5. Article
  6. Article
  7. Plant-Derived Compounds in Hemp Seeds (Molecules (Basel, Switzerland) · 2024
    Review
  8. Finally Freed-Plants (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Comparison of the Effects of Essential Oils fromInternational journal of molecular sciences · 2024
    Article
  11. Morphometric approaches toVegetation history and archaeobotany · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Chemical profiling ofHeliyon · 2023
    Article
  16. Article
  17. Review
  18. Interpol Review of Drug Analysis 2019-2022.Forensic science international. Synergy · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David Charles SimiyuDepartment of Applied Plant Science, College of Agriculture and Life Science, Chonnam National University, Gwangju 61186, Korea.ORCID 0000-0002-6956-6286
Jin Hoon JangDepartment of Applied Plant Science, College of Agriculture and Life Science, Chonnam National University, Gwangju 61186, Korea.ORCID 0000-0003-0306-5283
Ok Ran LeeDepartment of Applied Plant Science, College of Agriculture and Life Science, Chonnam National University, Gwangju 61186, Korea.ORCID 0000-0002-6928-5863

Funding

Basic Science Research Program through the National Research Foundation of Korea 2019R1A2C1004140New Breeding Technologies Development Program, Rural Development Administration, Republic of Korea PJ01652301
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioengineeringCannabis sativahaploid inductionhemp

Identifiers

PMID35567237
PMCPMC9104644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.